202 related articles for article (PubMed ID: 30729333)
1. The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer.
Keshavarzi Z; Janghorban R; Alipour S; Tahmasebi S; Jokar A
Support Care Cancer; 2019 Apr; 27(4):1325-1334. PubMed ID: 30729333
[TBL] [Abstract][Full Text] [Related]
2. Investigating the effect of vitamin D vaginal suppository on sexual function among postmenopausal women: study protocol for a randomized controlled trial.
Sarebani Z; Alimoradi Z; Aali E; Mirzadeh M; Chegini V; Abbaspour M; Griffiths MD
BMC Womens Health; 2020 Feb; 20(1):27. PubMed ID: 32070323
[TBL] [Abstract][Full Text] [Related]
3. The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial.
Zohrabi I; Abedi P; Ansari S; Maraghi E; Shakiba Maram N; Houshmand G
BMC Womens Health; 2020 May; 20(1):108. PubMed ID: 32429977
[TBL] [Abstract][Full Text] [Related]
4. Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy.
Mariani L; Gadducci A; Vizza E; Tomao S; Vici P
Gynecol Endocrinol; 2013 Jan; 29(1):25-9. PubMed ID: 22994445
[TBL] [Abstract][Full Text] [Related]
5. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial.
Yaralizadeh M; Abedi P; Najar S; Namjoyan F; Saki A
Maturitas; 2016 Feb; 84():75-80. PubMed ID: 26617271
[TBL] [Abstract][Full Text] [Related]
6. Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause.
Kamronrithisorn T; Manonai J; Vallibhakara SA; Sophonsritsuk A; Vallibhakara O
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32967068
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.
Archer DF; Goldstein SR; Simon JA; Waldbaum AS; Sussman SA; Altomare C; Zhu J; Yoshida Y; Schaffer S; Soulban G
Menopause; 2019 Jan; 26(6):611-621. PubMed ID: 30694917
[TBL] [Abstract][Full Text] [Related]
8. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors.
Davis SR; Robinson PJ; Jane F; White S; White M; Bell RJ
J Clin Endocrinol Metab; 2018 Nov; 103(11):4146-4154. PubMed ID: 30239842
[TBL] [Abstract][Full Text] [Related]
9. Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
Gold D; Nicolay L; Avian A; Greimel E; Balic M; Pristauz-Telsnigg G; Tamussino K; Trutnovsky G
Maturitas; 2023 Jan; 167():1-7. PubMed ID: 36279690
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial.
Costantino D; Guaraldi C
Eur Rev Med Pharmacol Sci; 2008; 12(6):411-6. PubMed ID: 19146203
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E as alternative local treatment in genitourinary syndrome of menopause: a randomized controlled trial.
Golmakani N; Parnan Emamverdikhan A; Zarifian A; Sajadi Tabassi SA; Hassanzadeh M
Int Urogynecol J; 2019 May; 30(5):831-837. PubMed ID: 29971469
[TBL] [Abstract][Full Text] [Related]
12. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause.
Le Donne M; Caruso C; Mancuso A; Costa G; Iemmo R; Pizzimenti G; Cavallari V
Arch Gynecol Obstet; 2011 Jun; 283(6):1319-23. PubMed ID: 20577750
[TBL] [Abstract][Full Text] [Related]
13. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial.
Portman D; Palacios S; Nappi RE; Mueck AO
Maturitas; 2014 Jun; 78(2):91-8. PubMed ID: 24679891
[TBL] [Abstract][Full Text] [Related]
14. Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy.
Bruyniks N; Nappi RE; Castelo-Branco C; de Villiers TJ; Simon J
Climacteric; 2016; 19(1):60-5. PubMed ID: 26669628
[TBL] [Abstract][Full Text] [Related]
15. Effect of Foeniculum vulgare (fennel) on vaginal atrophy in postmenopausal women: A double-blind, randomized, placebo-controlled trial.
Ghazanfarpour M; Shokrollahi P; Khadivzadeh T; Baharian Sharghi N; Mirzaii Najmabadi K; Babakhanian M; Jafarian AH
Post Reprod Health; 2017 Dec; 23(4):171-176. PubMed ID: 28990439
[TBL] [Abstract][Full Text] [Related]
16. Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy.
Goldstein SR; Bachmann GA; Koninckx PR; Lin VH; Portman DJ; Ylikorkala O;
Climacteric; 2014 Apr; 17(2):173-82. PubMed ID: 23984673
[TBL] [Abstract][Full Text] [Related]
17. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.
Bachmann GA; Komi JO;
Menopause; 2010; 17(3):480-6. PubMed ID: 20032798
[TBL] [Abstract][Full Text] [Related]
18. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
[TBL] [Abstract][Full Text] [Related]
19. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
[TBL] [Abstract][Full Text] [Related]
20. A survey of the therapeutic effects of Vitamin E suppositories on vaginal atrophy in postmenopausal women.
Parnan Emamverdikhan A; Golmakani N; Tabassi SA; Hassanzadeh M; Sharifi N; Shakeri MT
Iran J Nurs Midwifery Res; 2016; 21(5):475-481. PubMed ID: 27904630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
